Glycated Albumin Market Growth To Be Extremely Strong in the near Future
Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.
The glycated albumin market is likely to grow in the near future as leading competitors in the market approve more revolutionary glycated albumin test kits. For example, the U.S. Food and Drug Administration (FDA) granted Asahi Kasei Pharma Corporation of Japan 510(k) clearance for its novel Lucica Glycated Albumin-L in vitro diagnostic assay kit created for the U.S. market in 2017. Glycated albumin in human serum can be measured quantitatively with Lucica Glycated Albumin-L on compatible clinical chemistry analyzers. The approval of novel glycated albumin test kits by major regulatory bodies is expected to fuel the growth of the glycated albumin kits/assays market.
Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.coherentmarketinsights.com/insight/request-sample/1957
Furthermore, rising diabetes incidence is predicted to boost demand for glycated albumin tests, propelling the worldwide glycated albumin assays market forward. For example, according to World Health Organization (WHO) estimates from 2014, over 8.5 percent of adults aged 18 and above, or around 422 million adults, were diagnosed with diabetes worldwide. According to a survey conducted by the Center for Disease Control and Prevention (CDC), in 2016, over 30.3 million people in the U.S. were diagnosed with diabetes, which accounts for around 9% of the U.S. population. Such high prevalence of diabetes globally will increase the demand for glycated albumin and therefore, is expected to drive the market growth.
Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).
Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.
Buy This Complete A Business Report With Flat US $2000 Off @
By Product Type :
- Human Glycated Albumin
- Animal Glycated Albumin
- Type 1 Diabetes
- Type 2 Diabetes
By End User:
- Diagnostic Centers
- Research Institutes
Request Free research report Brochure @
Table of Content
Global Glycated Albumin Market Research Report
Section 1: Global Glycated Albumin Industry Overview
Section 2: Global Economic Impact on Glycated Albumin Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Glycated Albumin Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Ask Analyst for Customization and Explore full report with TOC & List of Figures:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire